首页> 外文期刊>AACN advanced critical care >Antibody-Mediated Rejection in Solid Organ Transplant
【24h】

Antibody-Mediated Rejection in Solid Organ Transplant

机译:固体器官移植中的抗体介导的排斥反应

获取原文
获取原文并翻译 | 示例
           

摘要

Within a little more than a decade, the transplant of human organs for end-stage organ disease became a reality.The early barriers to successful long-term graft and patient survival were related to the inability to effectively control the immune system such that it would not attack the donor tissue but would still recognize and destroy invading organisms and cells. As immunosuppres-sive therapy has been refined and proper matching of donors and recipients has been improved, hyperacute rejection has become a rare occurrence and acute rejection has been markedly controlled. However, antibody-mediated rejection remains an important impediment to increased survival of transplanted organs. This article provides readers with a broad overview of the immune system, discusses mechanisms of transplant rejection, and details prevention, detection, and treatment of antibody-mediated rejection in solid organ transplant.
机译:在几十多年来,人体器官用于终末期器官疾病的移植成为现实。成功的长期移植物和患者存活的早期障碍与无法有效控制免疫系统,使其是有关的 不攻击捐赠组织,但仍然会识别并摧毁入侵的生物体和细胞。 由于免疫疗化治疗的疗法得到了精致和适当的捐助者和接受者的匹配得到了改善,超急性排斥反应已成为罕见的发生,急性排斥量明显控制。 然而,抗体介导的抑制仍然是对移植器官增加生存的重要障碍。 本文为读者提供了广泛的免疫系统概述,讨论了移植抑制的机制,以及在固体器官移植中抗体介导的抗体抑制的细节预防,检测和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号